Catalyst
Slingshot members are tracking this event:
Phase 2b interim data of CRS-207, GVAX Pancreas and nivolumab - STELLAR trial for Pancreatic cancer to be released 2H 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ADRO | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 17, 2016
Occurred Source:
https://www.novocure.com/novocure-presents-interim-stellar-results-at-iaslc-suggesting-treatment-with-tumor-treating-fields-plus-chemotherapy-may-extend-survival-of-patients-with-mesothelioma/
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2b Interim Data, Crs-207, Gvax Pancreas, Nivolumab, Stellar Trial, Pancreatic Cancer, Ladd-based Immunotherapy
